We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$356B
AUM Growth
+$14.1B
Cap. Flow
-$4.79B
Cap. Flow %
-1.35%
Top 10 Hldgs %
30.2%
Holding
3,385
New
54
Increased
1,101
Reduced
1,417
Closed
52

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$542M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$499M
3
MNST icon
Monster Beverage
MNST
+$326M
4
NVDA icon
NVIDIA
NVDA
+$316M
5
MCD icon
McDonald's
MCD
+$302M

Sector Composition

Rank Sector Weight
1 Technology 30.77%
2 Financials 12.09%
3 Healthcare 11.08%
4 Consumer Discretionary 10.82%
5 Industrials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVT icon
1551
Clarivate
CLVT
$1.16B
$10.4M ﹤0.01%
1,458,289
-74,031
-5% -$472K
LCII icon
1552
LCI Industries
LCII
$2.65B
$10.3M ﹤0.01%
85,801
-111
-0.1% -$12.5K
AUB icon
1553
Atlantic Union Bankshares
AUB
$5.97B
$10.3M ﹤0.01%
273,793
-2,560
-0.9% -$96.3K
HNI icon
1554
HNI Corp
HNI
$3.59B
$10.3M ﹤0.01%
191,402
-2,454
-1% -$125K
LBPH
1555
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$10.3M ﹤0.01%
309,118
+149,129
+93% +$5.13M
ESGR
1556
DELISTED
Enstar Group
ESGR
$10.3M ﹤0.01%
32,033
-443
-1% -$144K
OEC icon
1557
Orion
OEC
$409M
$10.3M ﹤0.01%
577,557
+286,579
+98% +$5.52M
CORT icon
1558
Corcept Therapeutics
CORT
$12B
$10.3M ﹤0.01%
222,080
-1,285
-0.6% -$45.7K
VAL icon
1559
Valaris
VAL
$5.47B
$10.2M ﹤0.01%
183,730
-477
-0.3% -$31.2K
PPLI
1560
People Inc
PPLI
$3.1B
$10.2M ﹤0.01%
231,890
-12,033
-5% -$501K
FIVE icon
1561
Five Below
FIVE
$13.5B
$10.2M ﹤0.01%
115,776
+1,383
+1% +$116K
FFBC icon
1562
First Financial Bancorp
FFBC
$3.53B
$10.2M ﹤0.01%
405,326
-68,491
-14% -$1.72M
OGN icon
1563
Organon & Co
OGN
$3.57B
$10.2M ﹤0.01%
534,184
+13,750
+3% +$285K
SJNK icon
1564
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
$10.2M ﹤0.01%
396,353
-397,140
-50% -$10M
NEOG icon
1565
Neogen
NEOG
$2.5B
$10.2M ﹤0.01%
606,247
-6,380
-1% -$105K
PRDO icon
1566
Perdoceo Education
PRDO
$2.12B
$10.2M ﹤0.01%
457,814
+31,694
+7% +$714K
VTLE
1567
DELISTED
Vital Energy
VTLE
$10.2M ﹤0.01%
378,081
+12,649
+3% +$468K
REX icon
1568
REX American Resources
REX
$1.41B
$10.2M ﹤0.01%
438,930
-61,524
-12% -$1.4M
CNMD icon
1569
CONMED
CNMD
$1.47B
$10.1M ﹤0.01%
140,946
-92,552
-40% -$6.53M
ARR
1570
Armour Residential REIT
ARR
$2.36B
$10.1M ﹤0.01%
496,873
+33,048
+7% +$674K
GLBE icon
1571
Global E Online
GLBE
$7.11B
$10.1M ﹤0.01%
263,261
-330
-0.1% -$11.6K
ACLX
1572
DELISTED
Arcellx
ACLX
$10.1M ﹤0.01%
120,896
-1,015
-0.8% -$67.6K
AMPH icon
1573
Amphastar Pharmaceuticals
AMPH
$916M
$10.1M ﹤0.01%
207,972
-93,617
-31% -$4.11M
OMCL icon
1574
Omnicell
OMCL
$1.68B
$10M ﹤0.01%
229,990
-10,512
-4% -$396K
SRLN icon
1575
State Street Blackstone Senior Loan ETF
SRLN
$5.36B
$10M ﹤0.01%
240,000

Similar funds

Nuveen's Q3 2024 Portfolio in Review

As of Q3 2024, Nuveen held 3,385 positions worth $356B, up 4.1% from $342B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 3.1%. Nuveen opened 54 new positions and exited 52, leaving the 3,385-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q3 2024 buy was Smurfit Westrock: 13,669,531 shares worth $676M.
  • Nuveen added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, an estimated $269M increase.
  • Nuveen's biggest Q3 2024 reduction was Microsoft, cutting an estimated $542M.
  • Nuveen fully exited iShares MSCI ACWI ETF in Q3 2024, selling an estimated $114M.
  • Nuveen's ten largest holdings make up 30% of its $356B portfolio in Q3 2024.
  • Nuveen opened 54 new positions and closed 52 in Q3 2024.
  • Nuveen's portfolio value rose 4.1% quarter-over-quarter to $356B.

Based on Nuveen's 13F filing for Q3 2024, filed 14 Nov 2024.